Futurera Pharma-Tech Private Limited
About Futurera Pharma-Tech Private Limited
Data last updated:
Futurera Pharma-Tech Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74999KA2018PTC118949. Its GSTIN is 21AADCF5746J1ZO (Odisha). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rajachandra Akella Viswanadh and Chandra Sekhar Ayyalasomayajula.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No. C – 3 Apurva Ethreal Apartments 6th Cross D Silva Layout Whitefield, Bangalore, Karnataka, India – 560066.
As per the financials filed for FY 2023, the company reported a revenue of ₹11,391, a decline of 95% compared to the previous year. For the same year it recorded a net loss of ₹11,439 (net margin -100.4%) and EBITDA of ₹3,561 (EBITDA margin 31.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo. C – 3 Apurva Ethreal Apartments 6th Cross D Silva Layout Whitefield, Bangalore, Karnataka, India – 560066
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Futurera Pharma-Tech Private Limited FY 2024 filings available
Futurera Pharma-Tech Private Limited reported revenue of ₹11,391 (down 95% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Futurera Pharma-Tech Private Limited
Revenue fell 95% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Futurera Pharma-Tech Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹11,391 | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3,561 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹11,439 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Futurera Pharma-Tech Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -100.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Futurera Pharma-Tech are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Futurera Pharma-Tech Private Limited
Futurera Pharma-Tech Private Limited is audited by PANKAJ KUMAR AGRAWAL & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PANKAJ KUMAR AGRAWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Futurera Pharma-Tech Private Limited
Futurera Pharma-Tech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajachandra Akella Viswanadh Also directs: Finvault Tech LLP, Evionics Innovations Private Limited, Evionics Service Network Private Limited and 4 more | Director | 01 Aug 2023 | 3 Years 2 Months | Current |
| Chandra Sekhar Ayyalasomayajula | Director | 28 Nov 2018 | 7 Years 10 Months | Current |
Ownership and Shareholding of Futurera Pharma-Tech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Futurera Pharma-Tech Private Limited
Futurera Pharma-Tech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Futurera Pharma-Tech Private Limited
Employment history and EPFO contributions of people linked to Futurera Pharma-Tech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Futurera Pharma-Tech Private Limited
Futurera Pharma-Tech Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Nistala Sriramamurty ceased to be Director on 01 Aug 2023.
Credit Ratings, Litigation & Regulatory Alerts for Futurera Pharma-Tech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Futurera Pharma-Tech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Futurera Pharma-Tech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Futurera Pharma-Tech Private Limited
Futurera Pharma-Tech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AADCF5746J1ZO | Odisha | Active | 20 Jun 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Futurera Pharma-Tech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Futurera Pharma-Tech Private Limited
Futurera Pharma-Tech is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 November 2018 (8+ years old) and is registered under CIN U74999KA2018PTC118949.
Futurera Pharma-Tech reported revenue of ₹11,391 for FY 2023 (down 95% YoY).
Futurera Pharma-Tech has 2 current directors:
- Rajachandra Akella Viswanadh - Director
- Chandra Sekhar Ayyalasomayajula - Director
Futurera Pharma-Tech reported a net loss of ₹11,439 (net margin -100.4%) and EBITDA of ₹3,561 (EBITDA margin 31.3%) for FY 2023, as per its filed financial statements.
The GSTIN of Futurera Pharma-Tech is 21AADCF5746J1ZO, registered in Odisha. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Futurera Pharma-Tech is U74999KA2018PTC118949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Futurera Pharma-Tech was incorporated on 28 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Nistala Sriramamurty ceased to be Director on 01 Aug 2023. Rajachandra Akella Viswanadh was appointed as Director on 01 Aug 2023. Chandra Sekhar Ayyalasomayajula was appointed as Director on 28 Nov 2018.
The registered office of Futurera Pharma-Tech is at No. C – 3 Apurva Ethreal Apartments 6th Cross D Silva Layout Whitefield, Bangalore, Karnataka, India – 560066.
Futurera Pharma-Tech has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.